Parents Against Cancer Logo
Home

 

Parents Against Cancer & Blood Disorders Parents Against Cancer Logo
Home

Up ] About Us ] Newsletter ] Articles ] For Our Families ] From Our Parents ] Encouragement ] Funny Pages ] Links ] Make A Donation ] Contact Us ] Events ] Support Groups ] Camp ] Special Kids ] Pictures ]


Hemophelia
                                           BLEEDING DISORDERS NETWORKING
First Step Program  provides  a means for parents
 in our area to meet and network with other
families affected by hemophilia and other bleeding disorders. 
For more information contact :
The Hemophilia Foundation of  Southern California
33 S. Catalina Avenue, Suite 102 Pasadena, California 91106
Phone (626) 793-6192 Fax (626) 796-5605
email hfsc@earthlink.net
Web: www.hemosocal.org

Hemophelia
By Teddi Softley, Ph.D.

The disease known as hemophilia was mentioned in written records as early as 2000 years ago.  By the fifth century A.D. hemophilia was recognized as an inherited disease that affects mostly males.  The transmission of hemophilia from carrier mothers to their sons was first described in the United States in 1803.  The presence of the disease among members of many European royal families during the 19th and 20th centuries originated with Queen Victoria, a carrier whose descendants introduced the disorder to the royal houses of Russia, Germany and Spain.  In the 1980’s, hemophilia made the headlines as one the first human disorders in which the responsible gene was identified and cloned.

Cause
There are more than  ten substances in the blood, called clotting factors that must work in a specific sequence to produce blood clotting.  An abnormality in any of these factors can lead to bleeding problems.  Hemophilia is caused by a defect or deficiency in either of two clotting substances: factor VIII, which causes hemophilia A, or factor IX, which causes hemophilia B.  About 15,000 to 20,000 people in the U.S. have hemophilia.  Hemophilia occurs in 1 in 5,000 live male births.  Defects or deficiencies in other blood factors, such as factors I, II, VII, X, XI and XIII, cause other coagulation disorders, all of them much rarer than hemophilia A and B.

Besides hemophilia, there are a number of other inherited bleeding disorders.  Chief among these is von Willebrand disease which affects about 1.3 million people in the U.S., both male and female.  Von Willebrand disease is not considered a rare disorder. 

Inheritance
The defective hemophilia gene is passed down through females who are carriers of the disorder.  The result can be the birth of sons with hemophilia, daughters who are carriers, or children who are unaffected.  A male with hemophilia automatically passes the  gene to his daughters all of whom are carriers.  About one-third of individuals affected develop  hemophilia through a spontaneous gene mutation.  This means that they were born to women with no history of hemophilia in their families.  In some extremely rare cases, hemophilia may occur in women.

Severity

In severe hemophilia, the clotting factor activity is less than 1 percent of the normal range.  In addition to prolonged bleeding due to injury or surgery, spontaneous internal bleeding may occur in parts of the body such as joints, muscles, and sometimes, the head.  This can cause stroke or damage to internal organs such as, joints or muscles.  In moderate hemophilia, clotting activity is between 1 and 5 percent of the normal range.  Spontaneous bleeding does not usually occur, but minor injury may cause prolong bleeding.  In mild hemophilia, clotting activity is  above 5 percent.  Bleeding usually only occurs as a result of trauma, surgery, or invasive dental procedures.

Treatment
Treatment consists of replacing the deficient clotting factor by the intravenous infusion of highly purified factor derived from human blood.  Synthetic (recombinant) factors , though expensive, have become the treatment of choice and the standard of care.

These products are produced in the laboratory, without the use of human blood. In the 1970s, the advent of concentrated clotting factor enabled people with hemophilia to infuse themselves at home.  Many patients take prophylactic doses of  the factor two to three days a week to prevent and protect their joints.  Mild hemophiliacs may respond to other medications such as DDAVP which is available in an intravenous and nasal spray form.

Should Children with Hemophilia Participate in Sports and Recreational Activities

Studies by orthopedists and physical therapists have shown that the child with hemophilia whose joints are supported by well-developed muscles is better able to withstand the trauma of daily living.  Furthermore, children with strong musculoskeletal systems have fewer spontaneous bleeding episodes.  The development of strong muscles can best be accomplished through regular physical exercise, something that should be started early and continued throughout adult life.

Despite the benefits of participation in sports, there are some legitimate concerns among parents and school staff.  One concern is that the child may try an athletic activity and fail, either because increased bleeding requires discontinuing the sport, or because they lack  the physical abilities to compete with their peers.  To lessen the likelihood of failure, a sport should be chosen that promises a relatively good chance of success.   Another concern is that playing a sport may increase the frequency of bleeding episodes.  

While it is obvious that some bleeding may result from participation in a sport, health care providers and staff members of camps for children with bleeding disorders report that generally there are fewer bleeding episodes when children  engage in physical activities on a regular basis than when they are sedentary.  When a particular sport or activity is followed frequently by bleeding, that activity should be reevaluated.

The National Hemophilia Foundation has recommended that children with hemophilia participate in sports and recreational activities.  However, each sport activity should be evaluated by assessing the risk benefit ratio for the patient.  For the purpose of evaluation, sports activities have been divided into three categories:

Category 1-- Recommended sports in which most individuals with hemophilia can participate safely.

Category 2--Sports in which the physical, social, and psychological benefits often outweigh the risks.

Category 3—Sports for which the risks  outweigh the benefits.  The nature of these activities make them dangerous even for those without hemophilia.

Activity/Category

Golf/1           
A sport that can be carried through adult life.            

Swimming/1            
It  provides  excellent musculoskeletal training.

Baseball/2            
Helmets are encouraged. No base-sliding/pitching .

Basketball/2            
Consult with M.D. , wear protective gear for joints.

Bowling/2            
May cause excessive strain to the elbow.

Frisbee/2         
Avoid being hit by a fast moving object.

Gymnastics/2 
May be okay for those without musculoskeletal damage.

Horseback riding/2                     
A well-fitted helmet is needed.  Major risks for everyone.

Ice Skating/2
Stress on the ankles. Avoid if arthropathy is present.

Jogging/Running/2
Trauma to the  knees and ankles can lead to arthropathy .

Roller Skating/2
Frequent falls can lead to occasional fractures.

Skiing/2
Risk of severe injury.             

Soccer/2
Risk of damage to the ankle and lower limbs.

Tennis/2
Stressful to the joints. Difficult if arthropathy is present.       

Volleyball/2
Risky when highly competitive.

Water-skiing/2
Head trauma is a major concern. 

Weightlifting/2
Using lighter weights is less risky.

Boxing/3                     
Not recommended.

Football/3                     
Not recommended. Risks to the head, neck and spine.

Hockey/3                     
Not recommended. High risk of severe traumatic injuries.

Motorcycling/3                     
Extremely dangerous for anyone.

Racquetball/3                  
Not recommended. Frequent injuries.

Skateboarding/3                     
Not recommended.  Severe injuries to the ankles.

Wrestling/3                     
Not recommended.

Jonathan Jaques Children’s Cancer Center provides state of the art comprehensive treatment to over 50 children with hemophilia and other clotting disorders.  We provide excellent education and teaching, medical care, psychosocial support, and rehabilitation services designed to meet the needs of patients and their families.

If additional information is needed, please call Susan Shannon, RN, MSN, CPNP at (562) 933-8600.

Other resources:

National Hemophilia Foundation - You can call and request information on specific topics for free, (800)  42-Handi.

Internet: www.hemophiliagalaxy.com has educational module on line.

www.hemosocal.com or (800) 371-4123.



Enter Keywords Above to Search Our Site

Sickle Cell Anemia ] [ Hemophelia ]


Dedicated To Children With Cancer & Blood Disorders


Parents Against Cancer, Inc.
P.O. Box 92644 ·Long Beach, CA 90809-2644

Jonathan Jaques Children's Cancer Center
Miller Children's Hospital, Long Beach Memorial Medical Center

Please contact webmaster if you have questions about this site or find any broken links.


General Disclaimer: This web site and any links herein are provided for informational purposes only and are not intended to render medical advice.  If you suspect your child has a health problem, you should consult your health care provider.